Cardiovascular Atlas
About
Menu

Guideline recommendations

A guideline recommending for, against or only in research, from the date the recommendation took effect.

20 events of 208. A year or a month is never shown as a day, and a year-only date sorts below the dated events of that year. Expected future events are on the calendar.

2025 1

  1. Recommended Salt substitution (lower-sodium, potassium-containing salt)

    Issued by: World Health Organization · Where: Global · Strength: Conditional recommendation

    Source: Use of lower-sodium salt substitutes: WHO guideline

2022 5

  1. Recommended Finerenone

    Issued by: Kidney Disease: Improving Global Outcomes (KDIGO) · Where: Not stated · Strength: Consensus statement; the report prints no class of recommendation

    Source: Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)

  2. Evidence is insufficient to recommend for or against Statins

    Issued by: U.S. Preventive Services Task Force · Where: United States · Strength: I statement (evidence insufficient)

    Source: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement

  3. Recommended Statins

    Issued by: U.S. Preventive Services Task Force · Where: United States · Strength: B recommendation

    Source: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement

  4. Recommended against Aspirin

    Issued by: U.S. Preventive Services Task Force · Where: United States · Strength: D recommendation

    Source: Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement

  5. Recommended SGLT2 inhibitors (drug class)

    Issued by: American College of Cardiology · Where: Not stated · Strength: Class of Recommendation 1a, as printed on the ACC summary page

    Source: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

2021 9

  1. Recommended Blood pressure lowering medicine

    Issued by: World Health Organization · Where: Global · Strength: Strong recommendation, moderate- to high-certainty evidence

    Source: Guideline for the pharmacological treatment of hypertension in adults (World Health Organization, 2021)

  2. Recommended Blood pressure lowering medicine

    Issued by: World Health Organization · Where: Global · Strength: Strong recommendation, moderate- to high-certainty evidence

    Source: Guideline for the pharmacological treatment of hypertension in adults (World Health Organization, 2021)

  3. Recommended Blood pressure lowering medicine

    Issued by: World Health Organization · Where: Global · Strength: Conditional recommendation, moderate- to high-certainty evidence

    Source: Guideline for the pharmacological treatment of hypertension in adults (World Health Organization, 2021)

  4. Recommended Blood pressure lowering medicine

    Issued by: World Health Organization · Where: Global · Strength: Strong recommendation, high-certainty evidence

    Source: Guideline for the pharmacological treatment of hypertension in adults (World Health Organization, 2021)

  5. Recommended Blood pressure lowering medicine

    Issued by: World Health Organization · Where: Global · Strength: Conditional recommendation, moderate-certainty evidence

    Source: Guideline for the pharmacological treatment of hypertension in adults (World Health Organization, 2021)

  6. Recommended Blood-pressure lowering to a target

    Issued by: World Health Organization · Where: Global · Strength: Strong recommendation, moderate-certainty evidence

    Source: Guideline for the pharmacological treatment of hypertension in adults (World Health Organization, 2021)

  7. Recommended Blood-pressure lowering to a target

    Issued by: World Health Organization · Where: Global · Strength: Strong recommendation, moderate-certainty evidence

    Source: Guideline for the pharmacological treatment of hypertension in adults (World Health Organization, 2021)

  8. Recommended Blood-pressure lowering to a target

    Issued by: World Health Organization · Where: Global · Strength: Conditional recommendation, moderate-certainty evidence

    Source: Guideline for the pharmacological treatment of hypertension in adults (World Health Organization, 2021)

  9. Recommended Hypertension treatment by nonphysician professionals, such as pharmacists and nurses

    Issued by: World Health Organization · Where: Global · Strength: Conditional recommendation, low-certainty evidence

    Source: Guideline for the pharmacological treatment of hypertension in adults (World Health Organization, 2021)

2020 1

  1. Recommended Transcatheter aortic valve replacement (TAVR)

    Issued by: American College of Cardiology · Where: Not stated · Strength: Class 1, from the label (all Class 1) that introduces the list of rules, which includes this one

    Source: 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

2019 4

  1. Recommended Ambulatory blood pressure monitoring (ABPM)

    Issued by: National Institute for Health and Care Excellence · Where: GB-ENG (United Kingdom) · Strength: Not labeled on the fetched page. The recommendation uses the verb offer.

    Sources: Hypertension in adults: diagnosis and management (NICE guideline NG136), Recommendations chapter; Making decisions using NICE guidelines; NICE terms and conditions, including the Notice of Rights

  2. Recommended Home blood pressure monitoring

    Issued by: National Institute for Health and Care Excellence · Where: GB-ENG (United Kingdom) · Strength: Not labeled on the fetched page. The recommendation uses the verb offer.

    Sources: Hypertension in adults: diagnosis and management (NICE guideline NG136), Recommendations chapter; Making decisions using NICE guidelines; NICE terms and conditions, including the Notice of Rights

  3. Recommended Blood-pressure lowering to a target

    Issued by: National Institute for Health and Care Excellence · Where: Not stated · Strength: Not labeled on the fetched page. The recommendation uses imperative wording (directive verbs to lower the pressure and to keep it there).

    Sources: Hypertension in adults: diagnosis and management (NICE guideline NG136), Recommendations chapter; Making decisions using NICE guidelines

  4. Recommended against Salt substitution (lower-sodium, potassium-containing salt)

    Issued by: National Institute for Health and Care Excellence · Where: GB-ENG (United Kingdom) · Strength: Not labeled on the fetched page. The caution uses the wording should not be used.

    Sources: Hypertension in adults: diagnosis and management (NICE guideline NG136), Recommendations chapter; NICE terms and conditions, including the Notice of Rights